| Primary |
| Postpartum Haemorrhage |
58.1% |
| Labour Induction |
16.2% |
| Uterine Atony |
7.4% |
| General Anaesthesia |
2.2% |
| Induced Labour |
2.2% |
| Ovulation Induction |
1.5% |
| Pulmonary Hypertension |
1.5% |
| Uterine Haemorrhage |
1.5% |
| Vaginal Haemorrhage |
1.5% |
| Abnormal Labour |
0.7% |
| Anaesthesia Procedure |
0.7% |
| Anticoagulant Therapy |
0.7% |
| Caesarean Section |
0.7% |
| Drug Exposure During Pregnancy |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Epidural Anaesthesia |
0.7% |
| Hypertension |
0.7% |
| Hypotension |
0.7% |
| Maintenance Of Anaesthesia |
0.7% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
0.7% |
|
| Postpartum Haemorrhage |
28.2% |
| Hypotension |
24.4% |
| Myocardial Ischaemia |
10.3% |
| Dyspnoea |
3.8% |
| Electrocardiogram St Segment Depression |
3.8% |
| Maternal Drugs Affecting Foetus |
3.8% |
| Vascular Resistance Systemic Decreased |
3.8% |
| Drug Ineffective |
2.6% |
| Right Atrial Pressure Increased |
2.6% |
| Shock Haemorrhagic |
2.6% |
| Vomiting |
2.6% |
| Amnesia |
1.3% |
| Arrhythmia |
1.3% |
| Arteriospasm Coronary |
1.3% |
| Blood Sodium Decreased |
1.3% |
| Cardiac Arrest |
1.3% |
| Cardio-respiratory Arrest |
1.3% |
| Chest Discomfort |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
| Drug Interaction |
1.3% |
|
| Secondary |
| Caesarean Section |
16.0% |
| Labour Induction |
16.0% |
| Medical Diet |
16.0% |
| General Anaesthesia |
12.0% |
| Drug Dependence |
8.0% |
| Induced Labour |
8.0% |
| Postpartum Depression |
8.0% |
| Pregnancy |
8.0% |
| Anticoagulant Therapy |
4.0% |
| Maintenance Of Anaesthesia |
4.0% |
|
| Coma |
16.7% |
| Hyperhidrosis |
16.7% |
| Blood Pressure Increased |
8.3% |
| Foetal Distress Syndrome |
8.3% |
| Foetal Heart Rate Decreased |
8.3% |
| Jaundice |
8.3% |
| Oedema Peripheral |
8.3% |
| Procedural Pain |
8.3% |
| Right Atrial Pressure Increased |
8.3% |
| Uterine Spasm |
8.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
11.5% |
| Depression |
10.3% |
| Pain |
10.3% |
| Deep Vein Thrombosis |
9.1% |
| Product Used For Unknown Indication |
7.9% |
| Anxiety |
6.7% |
| Nausea |
6.7% |
| Contraception |
6.3% |
| Labour Induction |
4.3% |
| Asthma |
4.0% |
| Blood Pressure Abnormal |
4.0% |
| Blood Disorder |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Hypersensitivity |
2.4% |
| Ill-defined Disorder |
2.4% |
| Diuretic Therapy |
2.0% |
| Hypertension |
2.0% |
| Panic Disorder |
2.0% |
| Procedural Pain |
2.0% |
| Acne |
1.6% |
|
| White Blood Cell Count Increased |
29.1% |
| Ventricular Septal Defect |
22.8% |
| Pain |
7.6% |
| Pre-eclampsia |
5.1% |
| Trisomy 21 |
3.8% |
| Cholelithiasis |
2.5% |
| Drug Ineffective |
2.5% |
| Foetal Heart Rate Deceleration |
2.5% |
| Infantile Colic |
2.5% |
| Jaundice Neonatal |
2.5% |
| Maternal Exposure During Pregnancy |
2.5% |
| Pulmonary Embolism |
2.5% |
| Uterine Rupture |
2.5% |
| Vaginal Haemorrhage |
2.5% |
| Vomiting |
2.5% |
| Cerebral Haemorrhage |
1.3% |
| Cholecystectomy |
1.3% |
| Cholecystitis Chronic |
1.3% |
| Convulsion |
1.3% |
| Deep Vein Thrombosis |
1.3% |
|
